Algorae Pharmaceuticals Ltd (LVCLF): ? NTCELL Clinical Study results to be...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	41
Posts	2953
Boards Moderated	4
Alias Born	05/19/2010

SJOGRINGO

Re: SJOGRINGO post# 64

Wednesday, 11/08/2017 10:04:23 PM

Wednesday, November 08, 2017 10:04:23 PM

?

NTCELL Clinical Study results to be announced on Friday 10 November

Results of NTCELL® Clinical Study in Parkinson’s

Results released to ASX on Friday 10 November

Company to host conference call on Friday 10 November at 2:00pm AEST / 4:00pm NZT

LCT has announced a trading halt ahead of the announcement of the results of the Phase IIb clinical study of NTCELL in Parkinson's disease on Friday 10 November.

Investor call

LCT CEO Ken Taylor and Principal Investigator Dr Barry Snow will host an investor call to discuss the results of the Phase IIb clinical study of NTCELL in Parkinson's disease on the day of the announcement.

Date: Friday 10 November 2017
Time: NZT 4:00pm, AEST 2:00pm

Conference ID: 3389168

Toll-free dial-in numbers for participants:
Australia - 1800 123 296
New Zealand - 0800 452 782
Canada - 1855 5616 766
China - 4001 203 085
Hong - Kong 800 908 865
India - 1800 3010 6141
Japan - 0120 985 190
Singapore - 800 616 2288
United Kingdom - 0808 234 0757
United States - 1855 293 1544
or
toll +61 2 8038 5221

Never buy/sell based on my posts.My posts are opinions
only.My positions are subject to change W/O
notice NOTICE: NSA reportedly monitors,copies,and
captures IP address of electronic communications to and from the USA.